Finding 1137170 (2023-006)

Material Weakness Repeat Finding
Requirement
H
Questioned Costs
-
Year
2023
Accepted
2025-05-19

AI Summary

  • Core Issue: Internal control weaknesses led to salary expenses charged outside the approved period of performance, risking compliance with federal guidelines.
  • Impacted Requirements: Compliance with 3 CFR Part 200 and 2 CFR Part 200.403 regarding allowable costs and proper expense recording.
  • Recommended Follow-Up: Collaborate with federal agencies to justify expenses, adjust budgets as needed, and improve invoice and payroll entry processes to ensure compliance.

Finding Text

Federal Agency: U.S. Department of Health and Human Services; U.S. Department of Housing and Urban Development Federal Program Name: Community Service Block Grant; Community Development Block Grant Assistance Listing Number: 93.569; 14.218 Pass-through Agency: Pennsylvania Department of Community and Economic Development; City of Bethlehem (CB); Northampton County (NC) Pass-Through Number: Contract #C000067069; Contract #C000082084; B-22-MC-42-0003 (CB) Award Period: April 1, 2020 – September 30, 2022; January 1, 2022 – December 31, 2027; January 1, 2022 - December 31, 2023 (CB); July 1, 2020 - December 31, 2022 (NC) Type of Finding: • Material Weakness in Internal Control over Compliance • Other Matters Criteria: 3 CFR Part 200 Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Award requires compliance with the provisions of period of performance. The Organization should have procedures and controls in place to ensure expenses are charged to a federal program within the approved period of performance. In addition, in accordance with 2 CFR Part 200.403, allowable costs should be determined in accordance with generally accepted accounting principles (GAAP), therefore payroll accruals should be appropriately reflected when recording program expenditures. Condition: During our testing, we noted there were several salary expenditures charged to the grant based on the payroll period ending date, however the costs were incurred for the period 12/24/22 - 1/6/23, which the first eight days were prior to the start of the period of performance. There was also one transaction selected for testing where no supporting documentation was able to be located and one transaction that was incurred after the period of performance for the program. Questioned Costs: No questioned costs above the $25,000 threshold have been identified. Context: During the review of community service block grant costs recorded at the beginning of the approved period of performance (January 2023), seventeen transactions charged to the federal program in January 2023 for salary and related payroll taxes were observed. A portion of these expenses was incurred before the start of the contract period, specifically covering the payroll period from 12/24/22 to 1/6/23, with the first eight days outside the approved period of performance. The total amount of these transactions was $11,606. Additionally, one transaction for facilities maintenance totaling $2,625 lacked supporting documentation. Furthermore, during testing of costs recorded towards the end of the period of performance (September 2022), there was one transaction for outside computer services amounting to $1,125, with the invoice indicating services performed in October 2022. During the testing of community development block grant costs recorded at the beginning of the approved period of performance (January 2023), seventeen transactions charged to the federal program in January 2023 for salary and related payroll taxes were noted, with a portion incurred prior to the start of the contract period. The total amount of these transactions was $1,079. Cause: The Organization recorded the transactions into the general ledger based on the payroll period ending date and invoice date rather than the date the transactions were incurred by the Organization. In addition, the Organization experienced turnover within the finance department and the missing supporting documentation was likely misfiled and therefore unable to be located. Effect: If the Organization includes expenses either incurred before the start date or after the end date of the approved period of performance, it could result in funds being required to be returned to the funding agency. Repeat Finding: The finding is a repeat of a finding in the immediately prior year. Prior year finding number was 2022-005. Recommendation: The Organization should work with the federal agency to provide additional documentation or justification for the expenses, or to adjust the budget or funding limits to ensure that all expenses are within the approved period of performance. It is important to address any period of performance findings as soon as possible to avoid potential penalties or repayment obligations. The Organization should also review its process of entering invoices and payroll related expenses into the accounting software to ensure the correct period is used for federal expenditures. View of Responsible Officials and Planned Corrective Action: Please refer to Community Action Committee of the Lehigh Valley, Inc. and subsidiaries’ Corrective Action Plan.

Categories

Allowable Costs / Cost Principles Period of Performance Material Weakness

Other Findings in this Audit

  • 560668 2023-003
    Material Weakness Repeat
  • 560669 2023-003
    Material Weakness Repeat
  • 560670 2023-003
    Material Weakness Repeat
  • 560671 2023-003
    Material Weakness Repeat
  • 560672 2023-003
    Material Weakness Repeat
  • 560673 2023-003
    Material Weakness Repeat
  • 560674 2023-003
    Material Weakness Repeat
  • 560675 2023-003
    Material Weakness Repeat
  • 560676 2023-003
    Material Weakness Repeat
  • 560677 2023-003
    Material Weakness Repeat
  • 560678 2023-003
    Material Weakness Repeat
  • 560679 2023-004
    Significant Deficiency
  • 560680 2023-004
    Significant Deficiency
  • 560681 2023-004
    Significant Deficiency
  • 560682 2023-004
    Significant Deficiency
  • 560683 2023-004
    Significant Deficiency
  • 560684 2023-004
    Significant Deficiency
  • 560685 2023-004
    Significant Deficiency
  • 560686 2023-004
    Significant Deficiency
  • 560687 2023-004
    Significant Deficiency
  • 560688 2023-004
    Significant Deficiency
  • 560689 2023-004
    Significant Deficiency
  • 560690 2023-005
    Material Weakness Repeat
  • 560691 2023-005
    Material Weakness Repeat
  • 560692 2023-005
    Material Weakness Repeat
  • 560693 2023-005
    Material Weakness Repeat
  • 560694 2023-005
    Material Weakness Repeat
  • 560695 2023-005
    Material Weakness Repeat
  • 560696 2023-005
    Material Weakness Repeat
  • 560697 2023-005
    Material Weakness Repeat
  • 560698 2023-005
    Material Weakness Repeat
  • 560699 2023-005
    Material Weakness Repeat
  • 560700 2023-005
    Material Weakness Repeat
  • 560701 2023-005
    Material Weakness Repeat
  • 560702 2023-005
    Material Weakness Repeat
  • 560703 2023-005
    Material Weakness Repeat
  • 560704 2023-005
    Material Weakness Repeat
  • 560705 2023-005
    Material Weakness Repeat
  • 560706 2023-005
    Material Weakness Repeat
  • 560707 2023-005
    Material Weakness Repeat
  • 560708 2023-005
    Material Weakness Repeat
  • 560709 2023-005
    Material Weakness Repeat
  • 560710 2023-005
    Material Weakness Repeat
  • 560711 2023-005
    Material Weakness Repeat
  • 560712 2023-005
    Material Weakness Repeat
  • 560713 2023-005
    Material Weakness Repeat
  • 560714 2023-005
    Material Weakness Repeat
  • 560715 2023-005
    Material Weakness Repeat
  • 560716 2023-005
    Material Weakness Repeat
  • 560717 2023-005
    Material Weakness Repeat
  • 560718 2023-005
    Material Weakness Repeat
  • 560719 2023-005
    Material Weakness Repeat
  • 560720 2023-005
    Material Weakness Repeat
  • 560721 2023-005
    Material Weakness Repeat
  • 560722 2023-006
    Material Weakness Repeat
  • 560723 2023-006
    Material Weakness Repeat
  • 560724 2023-006
    Material Weakness Repeat
  • 560725 2023-006
    Material Weakness Repeat
  • 560726 2023-006
    Material Weakness Repeat
  • 560727 2023-006
    Material Weakness Repeat
  • 560728 2023-006
    Material Weakness Repeat
  • 560729 2023-006
    Material Weakness Repeat
  • 560730 2023-006
    Material Weakness Repeat
  • 560731 2023-006
    Material Weakness Repeat
  • 560732 2023-006
    Material Weakness Repeat
  • 560733 2023-006
    Material Weakness Repeat
  • 560734 2023-006
    Material Weakness Repeat
  • 560735 2023-006
    Material Weakness Repeat
  • 560736 2023-006
    Material Weakness Repeat
  • 560737 2023-006
    Material Weakness Repeat
  • 560738 2023-006
    Material Weakness Repeat
  • 560739 2023-006
    Material Weakness Repeat
  • 560740 2023-006
    Material Weakness Repeat
  • 560741 2023-006
    Material Weakness Repeat
  • 560742 2023-006
    Material Weakness Repeat
  • 560743 2023-007
    Material Weakness
  • 560744 2023-007
    Material Weakness
  • 560745 2023-007
    Material Weakness
  • 560746 2023-007
    Material Weakness
  • 560747 2023-007
    Material Weakness
  • 560748 2023-007
    Material Weakness
  • 560749 2023-007
    Material Weakness
  • 560750 2023-007
    Material Weakness
  • 560751 2023-007
    Material Weakness
  • 560752 2023-007
    Material Weakness
  • 560753 2023-007
    Material Weakness
  • 560754 2023-007
    Material Weakness
  • 560755 2023-007
    Material Weakness
  • 560756 2023-007
    Material Weakness
  • 560757 2023-007
    Material Weakness
  • 560758 2023-007
    Material Weakness
  • 560759 2023-008
    Significant Deficiency
  • 560760 2023-008
    Significant Deficiency
  • 560761 2023-008
    Significant Deficiency
  • 560762 2023-008
    Significant Deficiency
  • 560763 2023-008
    Significant Deficiency
  • 560764 2023-008
    Significant Deficiency
  • 560765 2023-008
    Significant Deficiency
  • 560766 2023-008
    Significant Deficiency
  • 560767 2023-008
    Significant Deficiency
  • 560768 2023-008
    Significant Deficiency
  • 560769 2023-008
    Significant Deficiency
  • 560770 2023-008
    Significant Deficiency
  • 560771 2023-008
    Significant Deficiency
  • 560772 2023-008
    Significant Deficiency
  • 560773 2023-008
    Significant Deficiency
  • 560774 2023-008
    Significant Deficiency
  • 560775 2023-009
    Significant Deficiency
  • 560776 2023-009
    Significant Deficiency
  • 560777 2023-009
    Significant Deficiency
  • 560778 2023-009
    Significant Deficiency
  • 560779 2023-009
    Significant Deficiency
  • 560780 2023-009
    Significant Deficiency
  • 560781 2023-009
    Significant Deficiency
  • 560782 2023-009
    Significant Deficiency
  • 560783 2023-009
    Significant Deficiency
  • 560784 2023-009
    Significant Deficiency
  • 560785 2023-009
    Significant Deficiency
  • 560786 2023-009
    Significant Deficiency
  • 560787 2023-009
    Significant Deficiency
  • 560788 2023-009
    Significant Deficiency
  • 560789 2023-009
    Significant Deficiency
  • 560790 2023-009
    Significant Deficiency
  • 1137110 2023-003
    Material Weakness Repeat
  • 1137111 2023-003
    Material Weakness Repeat
  • 1137112 2023-003
    Material Weakness Repeat
  • 1137113 2023-003
    Material Weakness Repeat
  • 1137114 2023-003
    Material Weakness Repeat
  • 1137115 2023-003
    Material Weakness Repeat
  • 1137116 2023-003
    Material Weakness Repeat
  • 1137117 2023-003
    Material Weakness Repeat
  • 1137118 2023-003
    Material Weakness Repeat
  • 1137119 2023-003
    Material Weakness Repeat
  • 1137120 2023-003
    Material Weakness Repeat
  • 1137121 2023-004
    Significant Deficiency
  • 1137122 2023-004
    Significant Deficiency
  • 1137123 2023-004
    Significant Deficiency
  • 1137124 2023-004
    Significant Deficiency
  • 1137125 2023-004
    Significant Deficiency
  • 1137126 2023-004
    Significant Deficiency
  • 1137127 2023-004
    Significant Deficiency
  • 1137128 2023-004
    Significant Deficiency
  • 1137129 2023-004
    Significant Deficiency
  • 1137130 2023-004
    Significant Deficiency
  • 1137131 2023-004
    Significant Deficiency
  • 1137132 2023-005
    Material Weakness Repeat
  • 1137133 2023-005
    Material Weakness Repeat
  • 1137134 2023-005
    Material Weakness Repeat
  • 1137135 2023-005
    Material Weakness Repeat
  • 1137136 2023-005
    Material Weakness Repeat
  • 1137137 2023-005
    Material Weakness Repeat
  • 1137138 2023-005
    Material Weakness Repeat
  • 1137139 2023-005
    Material Weakness Repeat
  • 1137140 2023-005
    Material Weakness Repeat
  • 1137141 2023-005
    Material Weakness Repeat
  • 1137142 2023-005
    Material Weakness Repeat
  • 1137143 2023-005
    Material Weakness Repeat
  • 1137144 2023-005
    Material Weakness Repeat
  • 1137145 2023-005
    Material Weakness Repeat
  • 1137146 2023-005
    Material Weakness Repeat
  • 1137147 2023-005
    Material Weakness Repeat
  • 1137148 2023-005
    Material Weakness Repeat
  • 1137149 2023-005
    Material Weakness Repeat
  • 1137150 2023-005
    Material Weakness Repeat
  • 1137151 2023-005
    Material Weakness Repeat
  • 1137152 2023-005
    Material Weakness Repeat
  • 1137153 2023-005
    Material Weakness Repeat
  • 1137154 2023-005
    Material Weakness Repeat
  • 1137155 2023-005
    Material Weakness Repeat
  • 1137156 2023-005
    Material Weakness Repeat
  • 1137157 2023-005
    Material Weakness Repeat
  • 1137158 2023-005
    Material Weakness Repeat
  • 1137159 2023-005
    Material Weakness Repeat
  • 1137160 2023-005
    Material Weakness Repeat
  • 1137161 2023-005
    Material Weakness Repeat
  • 1137162 2023-005
    Material Weakness Repeat
  • 1137163 2023-005
    Material Weakness Repeat
  • 1137164 2023-006
    Material Weakness Repeat
  • 1137165 2023-006
    Material Weakness Repeat
  • 1137166 2023-006
    Material Weakness Repeat
  • 1137167 2023-006
    Material Weakness Repeat
  • 1137168 2023-006
    Material Weakness Repeat
  • 1137169 2023-006
    Material Weakness Repeat
  • 1137171 2023-006
    Material Weakness Repeat
  • 1137172 2023-006
    Material Weakness Repeat
  • 1137173 2023-006
    Material Weakness Repeat
  • 1137174 2023-006
    Material Weakness Repeat
  • 1137175 2023-006
    Material Weakness Repeat
  • 1137176 2023-006
    Material Weakness Repeat
  • 1137177 2023-006
    Material Weakness Repeat
  • 1137178 2023-006
    Material Weakness Repeat
  • 1137179 2023-006
    Material Weakness Repeat
  • 1137180 2023-006
    Material Weakness Repeat
  • 1137181 2023-006
    Material Weakness Repeat
  • 1137182 2023-006
    Material Weakness Repeat
  • 1137183 2023-006
    Material Weakness Repeat
  • 1137184 2023-006
    Material Weakness Repeat
  • 1137185 2023-007
    Material Weakness
  • 1137186 2023-007
    Material Weakness
  • 1137187 2023-007
    Material Weakness
  • 1137188 2023-007
    Material Weakness
  • 1137189 2023-007
    Material Weakness
  • 1137190 2023-007
    Material Weakness
  • 1137191 2023-007
    Material Weakness
  • 1137192 2023-007
    Material Weakness
  • 1137193 2023-007
    Material Weakness
  • 1137194 2023-007
    Material Weakness
  • 1137195 2023-007
    Material Weakness
  • 1137196 2023-007
    Material Weakness
  • 1137197 2023-007
    Material Weakness
  • 1137198 2023-007
    Material Weakness
  • 1137199 2023-007
    Material Weakness
  • 1137200 2023-007
    Material Weakness
  • 1137201 2023-008
    Significant Deficiency
  • 1137202 2023-008
    Significant Deficiency
  • 1137203 2023-008
    Significant Deficiency
  • 1137204 2023-008
    Significant Deficiency
  • 1137205 2023-008
    Significant Deficiency
  • 1137206 2023-008
    Significant Deficiency
  • 1137207 2023-008
    Significant Deficiency
  • 1137208 2023-008
    Significant Deficiency
  • 1137209 2023-008
    Significant Deficiency
  • 1137210 2023-008
    Significant Deficiency
  • 1137211 2023-008
    Significant Deficiency
  • 1137212 2023-008
    Significant Deficiency
  • 1137213 2023-008
    Significant Deficiency
  • 1137214 2023-008
    Significant Deficiency
  • 1137215 2023-008
    Significant Deficiency
  • 1137216 2023-008
    Significant Deficiency
  • 1137217 2023-009
    Significant Deficiency
  • 1137218 2023-009
    Significant Deficiency
  • 1137219 2023-009
    Significant Deficiency
  • 1137220 2023-009
    Significant Deficiency
  • 1137221 2023-009
    Significant Deficiency
  • 1137222 2023-009
    Significant Deficiency
  • 1137223 2023-009
    Significant Deficiency
  • 1137224 2023-009
    Significant Deficiency
  • 1137225 2023-009
    Significant Deficiency
  • 1137226 2023-009
    Significant Deficiency
  • 1137227 2023-009
    Significant Deficiency
  • 1137228 2023-009
    Significant Deficiency
  • 1137229 2023-009
    Significant Deficiency
  • 1137230 2023-009
    Significant Deficiency
  • 1137231 2023-009
    Significant Deficiency
  • 1137232 2023-009
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
21.023 Emergency Rental Assistance Program $7.34M
10.565 Commodity Supplemental Food Program $955,719
93.569 Community Services Block Grant $732,109
93.568 Low-Income Home Energy Assistance $202,538
10.569 Emergency Food Assistance Program (food Commodities) $140,754
97.024 Emergency Food and Shelter National Board Program $85,203
14.218 Community Development Block Grants/entitlement Grants $42,197
93.498 Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $27,801
81.042 Weatherization Assistance for Low-Income Persons $24,592
14.169 Housing Counseling Assistance Program $20,803
21.020 Community Development Financial Institutions Program $12,500
10.568 Emergency Food Assistance Program (administrative Costs) $8,332
21.027 Coronavirus State and Local Fiscal Recovery Funds $8,064
14.239 Home Investment Partnerships Program $315